
WFH expert panel discusses WHO EML and EMLc update
The global bleeding disorders community reached a major milestone in 2025, as the World Health Organization updated both its Essential
Year: 2026
Language: English
Author(s): World Federation of Hemophilia
People with bleeding disorders continue to face significant challenges in diagnosis, access to treatment and care around the world. To overcome these challenges, several WHO Member States—led by the government of Armenia, and co-sponsored by the governments of Bosnia & Herzegovina, Egypt, Georgia, Latvia, Malta, Morocco, Nepal, Paraguay, Spain, Sri Lanka and Togo—are leading efforts for the adoption of a dedicated WHA resolution to increase equitable access to diagnosis, treatment and care for people with bleeding disorders across the globe.
The WFH—as a non-state actor in official relations with the WHO since 1969— strongly supports this milestone initiative. This draft resolution, titled Global Action to Advance Health Equity for People with Hemophilia and Other Bleeding Disorders, has been officially proposed by the Member States for discussion and approval at the WHO 158th Session of the Executive Board, taking place in Geneva, Switzerland from February 2 to 7, 2026. This resolution would serve as an official WHO policy document and a commitment by the WHO and the national governments to address the health inequities faced by the bleeding disorders community worldwide.
In this informational webinar you can learn about the latest developments and concrete steps undertaken by the WHO Member States, led by Armenia, to pass this WHA resolution, learn about WFH advocacy in this regard, and find out how you and your organization can support and advocate for this initiative.
Date recorded: January 29, 2026.
The WFH does not engage in the practice of medicine and under no circumstances recommends particular treatment for specific individuals. For diagnosis or consultation on a specific medical problem, the WFH recommends that you contact your physician or local treatment centre. Before administering any products, the WFH urges patients to check dosages with a physician or hemophilia centre staff, and to consult the pharmaceutical company’s printed instructions.
The WFH does not promote any particular pharmaceutical product and any mention of any commercial brand in this presentation is strictly for educational purposes.

The global bleeding disorders community reached a major milestone in 2025, as the World Health Organization updated both its Essential
The presentations and discussions of the third edition of the WFH Global Policy and Access Summit (GPAS) center around increasing
The presentations and discussions of the second edition of the WFH Global Policy and Access Summit (GPAS) center around improving
In these sessions from the WFH 2022 World Congress, listen to Kate Khair, Luke Pembroke, Louis Marlow, Andrew Selvaggi, Robert

In this session from the Global Policy and Access Summit, Donna Coffin, Salome Mekhuzla, Carlos Safadi Marquez, John Gershman and

In this session from the Global Policy and Access Summit, Dan Hart, Margareth Ozelo, Hatoon Mohammed and Daniel Anibal Garcia